Skip to main content
. Author manuscript; available in PMC: 2010 Nov 10.
Published in final edited form as: Basic Res Cardiol. 2009 May 21;104(6):695–706. doi: 10.1007/s00395-009-0036-0

Table 1.

Hemodynamic data, lipid status, and serum-TNF-alpha and hs-CRP levels (measured at the end of the study).

Normal (n=6) High- Cholesterol (n=6) High- Cholesterol + Thalidomide (n=6) Normal + Thalidomide (n=6)
MAP (mmHg) 114±4 113±6 102±10 102±6
Body weight (kg) 59±4 61±3 53±2 57±3
Total Cholesterol (mg/dL) 86±3 356±48 351±47 87±9
LDL (mg/dL) 47±7 261±42 251±38 50±6
HDL (mg/dL) 35±4 87±7 96±12 33±3
Triglycerides (mg/dL) 21±3 38±6 $ 21±4 17±4
Serum TNF- alpha (pg/mL) 54±4 59±7 55±11 48±7
Serum hs- CRP (mg/dL) 0.045±0.012 0.040±0.005 0.032±0.005 0.044±0.007

Data are presented in Mean±SEM, p values in Table 2 legend.